A computational framework guided interleukin-15 identification as a cytokine enhancer for glypican-3-targeted CAR T in antigen-low liver cancer models. The study reported improved CAR T performance when IL-15 was added as a functional boost, positioning IL-15 as a strategy to improve efficacy where antigen density limits conventional targeting. The work highlights the use of large-scale modeling to prioritize functional immune enhancers, and it narrows attention to a specific pathway—IL-15—rather than broad screening for cytokines without a clear mechanistic rationale.